BAX Baxter International Inc. Stock Quote

BAX [NYSE]

Healthcare | Medical Instruments & Supplies | USA

Index	S&P 500	P/E	37.30	EPS (ttm)	2.18	Insider Own	0.10%	Shs Outstand	503.00M	Perf Week	4.07%
Market Cap	40.31B	Forward P/E	20.52	EPS next Y	3.96	Insider Trans	-3.84%	Shs Float	499.00M	Perf Month	0.63%
Income	1.12B	PEG	3.22	EPS next Q	0.94	Inst Own	87.40%	Short Float	1.50%	Perf Quarter	-0.91%
Sales	12.20B	P/S	3.31	EPS this Y	37.10%	Inst Trans	-0.41%	Short Ratio	2.29	Perf Half Y	-6.22%
Book/sh	16.89	P/B	4.82	EPS next Y	12.49%	ROA	5.70%	Target Price	94.20	Perf Year	0.33%
Cash/sh	6.33	P/C	12.85	EPS next 5Y	11.57%	ROE	13.10%	52W Range	73.12 - 88.32	Perf YTD	1.40%
Dividend	1.12	P/FCF	47.15	EPS past 5Y	24.40%	ROI	8.60%	52W High	-7.96%	Beta	0.61
Dividend %	1.38%	Quick Ratio	1.80	Sales past 5Y	3.20%	Gross Margin	39.60%	52W Low	11.17%	ATR	1.28
Employees	50000	Current Ratio	2.40	Sales Q/Q	14.00%	Oper. Margin	12.60%	RSI (14)	54.72	Volatility	1.60% 1.62%
Optionable	Yes	Debt/Eq	0.73	EPS Q/Q	23.00%	Profit Margin	9.20%	Rel Volume	0.22	Prev Close	81.36
Shortable	Yes	LT Debt/Eq	0.67	Earnings	Oct 28 BMO	Payout	45.90%	Avg Volume	3.28M	Price	81.29
Recom	2.20	SMA20	1.15%	SMA50	2.18%	SMA200	0.71%	Volume	105,313	Change	-0.09%

Sep-13-21

Upgrade

Cowen

Market Perform → Outperform

$98

Sep-03-21

Upgrade

Barclays

Equal Weight → Overweight

$93 → $100

May-25-21

Initiated

Barclays

Equal Weight

$93

Jan-29-21

Downgrade

Piper Sandler

Overweight → Neutral

$100 → $80

Jan-06-21

Downgrade

UBS

Buy → Neutral

$95 → $85

Dec-15-20

Downgrade

Goldman

Buy → Neutral

$96 → $85

Oct-01-20

Upgrade

Citigroup

Neutral → Buy

$94

Sep-04-20

Downgrade

Argus

Buy → Hold

Jun-24-20

Initiated

Oppenheimer

Outperform

$100

Mar-19-20

Upgrade

Stifel

Hold → Buy

$87 → $95

Mar-18-20

Upgrade

KeyBanc Capital Markets

Sector Weight → Overweight

$92

Mar-05-20

Initiated

Citigroup

Neutral

$94

Feb-13-20

Initiated

Goldman

Buy

$104

Jan-02-20

Upgrade

Evercore ISI

In-line → Outperform

$80 → $94

Dec-17-19

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$90 → $88

Jun-26-19

Initiated

KeyBanc Capital Markets

Sector Weight

Apr-08-19

Downgrade

Evercore ISI

Outperform → In-line

Jan-02-19

Upgrade

Morgan Stanley

Underweight → Overweight

Jan-02-19

Upgrade

Citigroup

Neutral → Buy

Nov-02-18

Upgrade

Argus

Hold → Buy

Oct-22-21 08:19AM	Baxter (BAX) to Report Q3 Earnings: What's in the Offing? Zacks
Oct-21-21 05:00PM	Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR CCL14 Test to Predict Persistent Severe Acute Kidney Injury Business Wire
03:03PM	Baxter International (BAX) Earnings Expected to Grow: Should You Buy? Zacks
12:33AM	Should You Be Selling Your Baxter (BAX) Position Already? Insider Monkey
Oct-13-21 04:15PM	Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference Business Wire
Oct-12-21 04:10AM	What's in Store for Intuitive Surgical's (ISRG) Q3 Earnings? Zacks
Oct-11-21 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings Zacks
Oct-04-21 01:43PM	Baxter International Inc. (BAX): Hedge Funds Are Snapping Up Insider Monkey
07:29AM	What Is The Ownership Structure Like For Baxter International Inc. (NYSE:BAX)? Simply Wall St.
Oct-01-21 06:05PM	Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Diversicare, DSP Group, ADTRAN, and Hill-Rom on behalf of Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
06:46AM	The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific Corp, Catalent, Baxter International and Hill-Rom Holdings Zacks
Sep-30-21 09:37AM	MedTech Thrives on M&A Frenzy: 3 Stocks to Focus on Zacks
Sep-27-21 04:05PM	Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors Business Wire
09:06AM	Baxter's (BAX) Premix Norepinephrine Now Available in U.S. Zacks
Sep-23-21 11:24AM	Baxter's Norepinephrine Wins FDA Nod For Low Blood Pressure Benzinga
09:00AM	Baxter Announces U.S. FDA Approval and Launch of Ready-to-use Cardiovascular Medicine Norepinephrine in Premix Formulation Business Wire
Sep-09-21 08:00AM	Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development GlobeNewswire
Sep-06-21 10:51AM	Baxter (BAX) to Benefit From Hill-Rom Buyout: Here's How Zacks
Sep-04-21 08:36AM	(HRC): Johnson Fistel Investigates Proposed Sale of Hill-Rom; Are Shareholders Getting a Fair Deal? GlobeNewswire
Sep-03-21 06:03PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Hill-Rom Holdings, Inc. PR Newswire
12:04PM	HILL-ROM ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of HRC and Encourages Investors to Contact the Firm GlobeNewswire
10:33AM	Hill-Rom (HRC) Agrees to Get Acquired by Baxter, Shares Jump Zacks
09:57AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Hill-Rom Holdings, Inc. Buyout GlobeNewswire
Sep-02-21 03:43PM	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Hill-Rom Holdings, Inc. PR Newswire
01:34PM	7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In InvestorPlace
09:52AM	Baxter to Buy Hill-Rom for $10.5 Billion After Prior Refusal Bloomberg
08:41AM	Baxter to Acquire Hillrom At $156/Share: See The Highlights Benzinga
07:19AM	Baxter to acquire Hillrom in all-cash deal with enterprise value of about $12.4 billion MarketWatch
07:14AM	UPDATE 1-Medtech firm Baxter to buy hospital-bed maker Hill-Rom for $10.5 bln Reuters
07:00AM	Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally Business Wire
04:03AM	ChargePoint Rises Premarket; Chewy, Five Below and Hormel Fall Investing.com
03:52AM	Hillrom Jumps as Baxter Buys Medical Equipment Maker for $12.4 Billion Investing.com
Aug-30-21 01:10PM	2 Little-Followed Stocks That Are Soaring Monday Motley Fool
11:53AM	Why Shares of Hill-Rom Holdings Are Surging This Morning Motley Fool
08:16AM	Baxter In Advanced Talks For $10B Hill Rom Buyout: WSJ Benzinga
05:28AM	Hill-Rom Stock Leaps as Baxter Is Said to Plan $10B Bid TheStreet.com
01:35AM	Hill-Rom Jumps on Report Baxter Wants to Buy It for $10 Billion Investing.com
Aug-29-21 06:59PM	Baxter Nears $10 Billion Deal to Buy Hill-Rom, Dow Jones Says Bloomberg
06:40PM	Baxter in advanced talks to acquire Hill-Rom for $10 billion -source Reuters
Aug-18-21 08:30AM	The Baxter International Foundation and UNICEF USA Announce Partnership to Improve Water Security in Colombia Business Wire
Aug-13-21 06:54AM	Baxter Recalls Dose IQ Software 9.0.x Used With Infusion Pumps Benzinga
Aug-11-21 09:19AM	Got $5,000? These 3 Solid Dividend Stocks Are Trading Near Their 52-Week Lows Motley Fool
07:00AM	Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys GlobeNewswire
Aug-10-21 02:41PM	Hill-Rom stock falls after BofA downgrade, extending pullback following longest win streak in 20 years MarketWatch
09:47AM	10 Best Healthcare Stocks to Buy According to Larry Robbins Glenview Capital Insider Monkey
Aug-02-21 04:15PM	Baxter Advances Enterprise Digital Transformation in Collaboration With AWS Business Wire
Jul-29-21 06:45PM	Why Hill-Rom Stock Jumped 13% This Week Motley Fool -5.53%
06:00PM	Baxter International Inc (BAX) Q2 2021 Earnings Call Transcript Motley Fool
04:15PM	Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit Business Wire
11:13AM	10 Medical Technology Stocks to Buy Insider Monkey
08:45AM	Baxter International (BAX) Q2 Earnings Surpass Estimates Zacks
08:37AM	Baxter (BAX) Q2 Earnings Surpass Estimates, Revenues Miss Zacks
08:00AM	CryoLife Announces Sale of PerClot to Baxter PR Newswire
08:00AM	Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio Business Wire
07:15AM	Baxter Reports Second-Quarter 2021 Results Business Wire
Jul-28-21 04:40PM	Why Shares of Hill-Rom Holdings Jumped Today Motley Fool
12:10PM	Why the Earnings Surprise Streak Could Continue for Baxter (BAX) Zacks
09:52AM	Hill-Rom Stock Rises After Rejecting Baxter's Buyout Offer TheStreet.com
Jul-23-21 07:53AM	Baxter (BAX) to Report Q2 Earnings: What's in the Cards? Zacks
Jul-22-21 03:03PM	Baxter International (BAX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Jul-15-21 08:00AM	Baxter Supports Analysis Demonstrating Clinical and Economic Benefits of Effective Intraoperative Blood Management for Surgical Patients Business Wire
Jul-12-21 06:30PM	Baxter Declares Quarterly Dividend Business Wire
Jul-09-21 10:13AM	Walgreens (WBA), VillageMD State 2021 Primary Healthcare Goal Zacks
07:30AM	QIAGEN's (QGEN) NeuMoDx HAdV Quant Assay Wins CE-IVD Mark Zacks
Jul-08-21 09:06AM	Amedisys' (AMED) VNA Assets Buyout Boosts Home Health-Hospice Zacks
08:00AM	Baxter Launches New 2030 Corporate Responsibility Commitment to Advance Environmental, Social and Governance Priorities Business Wire
Jul-07-21 09:02AM	IDEXX Laboratories (IDXX) Hits 52-Week High: What's Driving It? Zacks
08:36AM	QIAGEN (QGEN) Faces COVID-Support Sales Drop, Huge Debt Zacks
Jul-06-21 08:53AM	NVIDIA, Lumentum, Maravai LifeSciences, Baxter International and BellRing Brands highlighted as Zacks Bull and Bear of the Day Zacks
Jun-29-21 09:57AM	10 Best Dividend Stocks to Buy According to Al Gore and David Blood Insider Monkey
08:00AM	Baxter Announces $1.2 Million in New Scholarships and Grant Funding to Support Students Pursuing Health and Sciences at Historically Black Colleges and Universities in the United States Business Wire
Jun-28-21 10:13AM	Hedge Funds Are Selling Baxter International Inc. (BAX) Insider Monkey
01:51AM	Are Investors Undervaluing Baxter International Inc. (NYSE:BAX) By 23%? Simply Wall St.
Jun-24-21 04:48PM	10 Medical Device Stocks for 2021 Insider Monkey
Jun-15-21 04:15PM	Baxter to Host Second-Quarter 2021 Financial Results Conference Call for Investors Business Wire
Jun-09-21 10:30AM	Baxter's (BAX) Theranova-Enabled HDx Therapy Data Positive Zacks
Jun-08-21 08:30AM	Baxter Presents Data at 58th ERA-EDTA Congress Indicating Theranova May Reduce Cardiovascular Events and Hospitalizations Business Wire
Jun-07-21 08:11AM	Baxter (BAX) Unveils New Digital Health Module for PD Patients Zacks
Jun-02-21 08:30AM	Baxter Launches the Sharesource Analytics 1.0 Digital Health Module to Enhance Clinical Management of Home Dialysis Patients Business Wire
Jun-01-21 08:45AM	Baxter's (BAX) PrisMax 2 to Simplify Organ Support Therapies Zacks
May-29-21 03:13AM	Is It Smart To Buy Baxter International Inc. (NYSE:BAX) Before It Goes Ex-Dividend? Simply Wall St.
May-25-21 08:00AM	Baxter Launches PrisMax 2 System to Advance Critical Care Delivery for Patients and Hospitals Business Wire
May-20-21 06:23PM	Al Gore's Firm Packs Into Amazon in the 1st Quarter GuruFocus.com
May-17-21 02:22AM	Baxter International's (NYSE:BAX) Returns On Capital Are Heading Higher Simply Wall St.
May-10-21 04:44PM	FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic Benzinga
04:32PM	Was The Smart Money Right About Baxter International Inc. (BAX)? Insider Monkey
May-08-21 07:30AM	PepsiCo, Cardinal Health, and 3 Other Companies That Raised Their Dividends This Week Barrons.com
May-04-21 04:15PM	Baxter to Present at the UBS Global Healthcare Virtual Conference Business Wire
May-03-21 05:00PM	Baxter Increases Dividend and Declares Quarterly Dividend Business Wire
Apr-29-21 01:00PM	Baxter International Inc (BAX) Q1 2021 Earnings Call Transcript Motley Fool
09:00AM	Baxter (BAX) Q1 Earnings and Revenues Surpass Estimates Zacks
08:25AM	Baxter International (BAX) Q1 Earnings and Revenues Top Estimates Zacks
07:15AM	Baxter Reports First-Quarter 2021 Results Business Wire
Apr-28-21 09:13AM	Medical Products' Apr 29 Earnings Roster: TMO, BAX & More Zacks
Apr-26-21 12:10PM	Why Baxter (BAX) is Poised to Beat Earnings Estimates Again Zacks
08:18AM	Baxter (BAX) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-22-21 12:33PM	Baxter International (BAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-21-21 09:45AM	Baxter Recognized Globally for Inclusion Efforts Business Wire
08:00AM	Baxter Receives Grant From German Federal Ministry of Education and Research to Lead Extracorporeal Blood Purification Research Business Wire
Apr-17-21 03:43AM	How Many Baxter International Inc. (NYSE:BAX) Shares Do Institutions Own? Simply Wall St.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Martin Sean	SVP and General Counsel	Aug 02	Option Exercise	50.77	19,800	1,005,246	61,977	Aug 04 04:09 PM
Martin Sean	SVP and General Counsel	Aug 02	Sale	77.26	19,800	1,529,748	42,177	Aug 04 04:09 PM
Frye Andrew	SVP, President, APAC	Apr 12	Sale	84.79	10,999	932,605	9,041	Apr 14 04:04 PM
HELLMAN PETER S	Director	Apr 05	Option Exercise	31.26	4,990	155,987	30,389	Apr 07 06:55 PM
STROUCKEN ALBERT P L	Director	Apr 05	Option Exercise	31.26	4,990	155,987	36,886	Apr 07 06:57 PM
STROUCKEN ALBERT P L	Director	Apr 05	Sale	84.56	4,990	421,954	31,896	Apr 07 06:57 PM
HELLMAN PETER S	Director	Apr 05	Sale	84.56	4,990	421,954	25,399	Apr 07 06:55 PM
Martin Sean	SVP and General Counsel	Nov 02	Option Exercise	50.77	47,001	2,386,241	86,641	Nov 04 04:05 PM
Martin Sean	SVP and General Counsel	Nov 02	Sale	78.67	47,001	3,697,794	39,640	Nov 04 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience